On April 10, 2025, Xtant Medical Holdings, Inc. announced a stock sale agreement where major shareholders will sell approximately 73.1 million shares at $0.42 each, with Nantahala Capital Management set to acquire 57 million shares, resulting in them owning 49.1% of the company. Additionally, the company amended its credit agreements to adjust the ownership threshold for a change in control from 40% to 49.9%.